483 Wyeth BioPharma Division of Wyeth Pharmaceuticals Apr 2017

483 Wyeth BioPharma Division of Wyeth Pharmaceuticals Apr 2017

Debra Emerson FDA$119.00 - Available Now

FDA investigators audited the Wyeth BioPharma Division of Wyeth Pharmaceuticals - Andover, MA, United States facility and issued inspectional observations (via FDA 483) on 28 Apr 2017.

Product details

  • Category: Biologics
  • Inspection end: 28 Apr 2017
  • Location: Andover, United States
  • FEI: 1222181
Add To Cart